Recent Advances in Endometriosis Pathophysiology and Pharmacological Treatment

International journal of molecular sciences · 2024 · PMC11204003
OA: gold CC-BY-4.0
📄 Open PDF Full text JSON
⚙ AI-generated summary by gemini-2.5-flash-lite+body, 2026-07-14 ⓘ

This review discusses recent advances in understanding endometriosis pathophysiology and pharmacological treatments.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by claude@2026-07, 2026-07-14 · read from full text ⓘ

This paper is a review that outlines recent advances in endometriosis pathophysiology and pharmacological treatment approaches, drawing together developments across mechanistic and therapeutic areas. The authors discuss the underlying biological processes thought to contribute to endometriosis and summarize how medications have been studied in relation to these processes, though specific study methods are not described because the format is not an original experiment. The paper includes a disclosure that the author has had presentations and studies financed by Gedeon Richter and Bayer, and it otherwise states no additional conflicts of interest. This paper is centrally about endometriosis — it specifically reviews endometriosis pathophysiology and pharmacological treatment advances.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Full text 516 characters · extracted from epmc-fulltextxml · 2 sections · click to expand

Fn Group

Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Conflicts

R. Wenzl has held presentations for and has performed studies financed by Gedeon Richter and Bayer. The authors declare no conflict of interest.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: epmc-fulltextxml ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2024) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-08-10T06:11:17.106188+00:00
License: CC-BY-4.0 · commercial use OK · attribution required
Per Europe PMC